Sciencast Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,689
Closed -$1.58M 276
2025
Q4
$1.58M Buy
+7,689
New +$1.45M 0.22% 158
2024
Q3
Sell
-23,227
Closed -$2.28M 254
2024
Q2
$2.28M Buy
+23,227
New +$2.37M 0.79% 51
2023
Q3
Sell
-3,300
Closed -$311K 351
2023
Q2
$311K Buy
+3,300
New +$279K 0.25% 162
2022
Q2
$1.05M Buy
17,781
+10,427
+142% +$593K 0.24% 147
2022
Q1
$421K Buy
+7,354
New +$394K 0.1% 258
2019
Q1
Sell
-10,000
Closed -$485K 372
2018
Q4
$485K Buy
+10,000
New +$521K 0.43% 95
2018
Q3
Sell
-14,059
Closed -$689K 278
2018
Q2
$689K Buy
14,059
+4,821
+52% +$273K 0.64% 42
2018
Q1
$584K Buy
+9,238
New +$634K 0.29% 136
2017
Q4
Sell
-6,089
Closed -$374K 318
2017
Q3
$374K Buy
+6,089
New +$430K 0.21% 182
2017
Q1
Sell
-6,613
Closed -$476K 349
2016
Q4
$476K Buy
+6,613
New +$478K 0.65% 49
2016
Q3
Sell
-9,285
Closed -$724K 120
2016
Q2
$724K Buy
+9,285
New +$740K 0.32% 105

Other funds holding CAH

Sciencast Management's CAH Position: Q1 2026 in Review

Sciencast Management sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 7,689 shares — an estimated $1.58M sold.

Sciencast Management first reported a position in CAH in Q2 2016 and held it in 11 quarters. The position peaked at $2.28M in Q2 2024. 1,433 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Sciencast Management reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Sciencast Management sold 7,689 Cardinal Health shares in Q1 2026, an estimated $1.58M.
  • Sciencast Management first reported a position in Cardinal Health in Q2 2016 and held it in 11 quarters.
  • Sciencast Management's Cardinal Health position peaked at $2.28M in Q2 2024.
  • 1,433 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Sciencast Management's 13F filing for Q1 2026, filed 14 May 2026.